HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Susan R Kahn Selected Research

Compression Stockings

11/2014Postthrombotic syndrome: a 2014 update.
10/2014Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
4/2013Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.
2/2013Surgical treatment of moderate-to-severe post-thrombotic syndrome.
2/2012Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
2/2012Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
7/2008Postthrombotic syndrome in relation to vena cava filter placement: a systematic review.
6/2008Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
7/2004Review: elastic compression stockings prevent the postthrombotic syndrome in deep venous thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Susan R Kahn Research Topics

Disease

15Venous Thromboembolism
01/2015 - 08/2003
12Thrombosis (Thrombus)
11/2014 - 01/2006
9Thrombophilia
02/2015 - 01/2007
9Hemorrhage
01/2015 - 08/2003
9Venous Thrombosis (Deep-Vein Thrombosis)
11/2014 - 07/2004
7Neoplasms (Cancer)
03/2013 - 11/2003
6Postthrombotic Syndrome
08/2014 - 07/2004
4Pulmonary Embolism
02/2012 - 12/2007
4Inflammation
01/2010 - 08/2005
4Premature Birth (Birth, Premature)
01/2010 - 06/2009
3Pre-Eclampsia (Preeclampsia)
11/2015 - 01/2011
3Bacterial Vaginosis
07/2010 - 01/2010
3Thrombophlebitis
01/2007 - 08/2002
2Pregnancy Complications
11/2014 - 07/2007
2Ulcer
02/2013 - 02/2012
2Infarction
01/2010 - 06/2009
2Infection
01/2010 - 06/2009
2Urogenital Neoplasms
06/2007 - 05/2007
1Hemochromatosis (Bronze Diabetes)
08/2014
1Varicose Veins (Varicose Vein)
08/2014
1Venous Insufficiency
08/2014
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2013
1Hypotension (Low Blood Pressure)
02/2012
1Critical Illness (Critically Ill)
02/2012
1Rupture
01/2010
1Thromboembolism
03/2009
1Hyperpigmentation
08/2008
1Edema
08/2008
1Pain (Aches)
01/2008
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2007
1Prostatic Neoplasms (Prostate Cancer)
05/2007
1Hypertension (High Blood Pressure)
01/2007
1Autoimmune Diseases (Autoimmune Disease)
11/2006

Drug/Important Bio-Agent (IBA)

9Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2015 - 06/2007
7Warfarin (Coumadin)FDA LinkGeneric
03/2009 - 08/2003
6Vitamin KFDA Link
02/2012 - 03/2009
5Prothrombin (Factor II)IBA
09/2014 - 03/2003
5fondaparinux (Arixtra)FDA Link
02/2012 - 01/2004
4Dalteparin (Dalteparin Sodium)FDA Link
02/2015 - 07/2007
4AnticoagulantsIBA
03/2013 - 06/2007
3factor V LeidenIBA
09/2014 - 02/2009
3fibrin fragment D (D-dimer)IBA
01/2013 - 12/2007
3Fibronectins (Fibronectin)IBA
07/2010 - 01/2010
2cryptoxanthin (beta-cryptoxanthin)IBA
11/2015 - 09/2009
2CholesterolIBA
11/2015 - 06/2009
2Carotenoids (Carotene)IBA
11/2015 - 09/2009
2Vitamin A (Retinol)FDA LinkGeneric
11/2015 - 09/2009
2AntioxidantsIBA
11/2015 - 01/2015
2lycopeneIBA
11/2015 - 09/2009
2VitaminsIBA
01/2015 - 09/2009
2rivaroxabanIBA
02/2012 - 01/2012
2Heparin (Liquaemin)FDA LinkGeneric
02/2012 - 06/2008
2CytokinesIBA
01/2010 - 03/2009
2C-Reactive ProteinIBA
01/2010 - 08/2005
2Folic Acid (Vitamin M)FDA LinkGeneric
06/2009 - 02/2009
2HomocysteineIBA
06/2009 - 02/2009
2DNA (Deoxyribonucleic Acid)IBA
06/2009 - 02/2009
2Interleukin-6 (Interleukin 6)IBA
03/2009 - 08/2005
1LuteinIBA
11/2015
1Plasminogen Activators (Plasminogen Activator)IBA
11/2014
1CD31 AntigensIBA
11/2014
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2014
1Matrix MetalloproteinasesIBA
08/2014
1IronIBA
08/2014
1Vascular Endothelial Growth FactorsIBA
08/2014
1Proteins (Proteins, Gene)IBA
08/2014
1LipodermatosclerosisIBA
08/2014
1CollagenIBA
08/2014
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2013
1Carbon MonoxideIBA
01/2013
1apixabanIBA
01/2012
1ximelagatran (Exanta)IBA
01/2012
1Tyrosine (L-Tyrosine)FDA Link
01/2011
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2010
1Biological Markers (Surrogate Marker)IBA
01/2010
1MicronutrientsIBA
09/2009
1Fatty Acids (Saturated Fatty Acids)IBA
09/2009
1beta Carotene (Betacarotene)FDA Link
09/2009
1gamma-TocopherolIBA
09/2009
1TocopherolsFDA Link
09/2009
1HormonesIBA
06/2009
1Hydrocortisone (Cortisol)FDA LinkGeneric
06/2009
1Lipoproteins (Lipoprotein)IBA
06/2009
1HDL CholesterolIBA
06/2009
1ThrombinFDA Link
06/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2009
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
02/2009
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
12/2007
1coumarinIBA
06/2007
1Genetic Markers (Genetic Marker)IBA
01/2007
1Inflammation MediatorsIBA
01/2007
1Antiphospholipid AntibodiesIBA
11/2006

Therapy/Procedure

9Compression Stockings
11/2014 - 07/2004
7Catheters
11/2014 - 08/2002
2Vena Cava Filters (Inferior Vena Cava Filter)
03/2013 - 07/2008
1Arthroplasty
06/2013
1Drug Therapy (Chemotherapy)
02/2012
1Thrombolytic Therapy
02/2012
1Intensive Care (Surgical Intensive Care)
12/2011
1Bed Rest (Bedrest)
01/2008